Klotho, phosphate and FGF-23 in ageing and disturbed mineral metabolism (Q38115124)

29 August 2017

Klotho, phosphate and FGF-23 in ageing and disturbed mineral metabolism (English)

1 reference

29 August 2017

Makoto Kuro-o

1

1 reference

PubMed ID

23774819

29 August 2017

language of work or name

English

0 references

publication date

18 June 2013

1 reference

Nature Reviews Nephrology

29 August 2017

1 reference

29 August 2017

9

1 reference

29 August 2017

11

1 reference

29 August 2017

650-660

1 reference

https://scigraph.springernature.com/pub.10.1038/nrneph.2013.111

29 August 2017

0 references

cites work

A Bacterium That Can Grow by Using Arsenic Instead of Phosphorus

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.111

Phosphorus additives in food and their effect in dialysis patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.111

The phosphatonin pathway: new insights in phosphate homeostasis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.111

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.111

FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.111

Autosomal-dominant hypophosphatemic rickets (ADHR) mutations stabilize FGF-23

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.111

Regulation of fibroblast growth factor-23 signaling by klotho

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.111

Klotho converts canonical FGF receptor into a specific receptor for FGF23

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.111

Mutation of the mouse klotho gene leads to a syndrome resembling ageing

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.111

Promoter methylation confers kidney-specific expression of the Klotho gene

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.111

Cognition impairment in the genetic model of aging klotho gene mutant mice: a role of oxidative stress.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.111

Expression of Klotho protein in the inner ear.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.111

Impaired regulation of gonadotropins leads to the atrophy of the female reproductive system in klotho-deficient mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.111

FGF23 induces left ventricular hypertrophy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.111

Disruption of the klotho gene causes pulmonary emphysema in mice. Defect in maintenance of pulmonary integrity during postnatal life.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.111

Independent impairment of osteoblast and osteoclast differentiation in klotho mouse exhibiting low-turnover osteopenia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.111

Klotho, a gene related to a syndrome resembling human premature aging, functions in a negative regulatory circuit of vitamin D endocrine system

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.111

Initial FGF23-mediated signaling occurs in the distal convoluted tubule

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.111

Targeted deletion of Klotho in kidney distal tubule disrupts mineral metabolism.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.111

Molecular insights into the klotho-dependent, endocrine mode of action of fibroblast growth factor 19 subfamily members

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.111

Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.111

Identification of a hormonal basis for gallbladder filling.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.111

FGF19 as a postprandial, insulin-independent activator of hepatic protein and glycogen synthesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.111

FGF-21 as a novel metabolic regulator

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.111

Endocrine regulation of the fasting response by PPARalpha-mediated induction of fibroblast growth factor 21

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.111

FGF21 induces PGC-1alpha and regulates carbohydrate and fatty acid metabolism during the adaptive starvation response

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.111

Hepatic fibroblast growth factor 21 is regulated by PPARalpha and is a key mediator of hepatic lipid metabolism in ketotic states

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.111

Endocrine fibroblast growth factors 15/19 and 21: from feast to famine

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.111

Molecular cloning and expression analyses of mouse betaklotho, which encodes a novel Klotho family protein.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.111

BetaKlotho is required for metabolic activity of fibroblast growth factor 21

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.111

Tissue-specific expression of betaKlotho and fibroblast growth factor (FGF) receptor isoforms determines metabolic activity of FGF19 and FGF21

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.111

Vitamin D receptor in chondrocytes promotes osteoclastogenesis and regulates FGF23 production in osteoblasts

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.111

Endocrine FGFs and Klothos: emerging concepts

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.111

Role of hyperphosphatemia and 1,25-dihydroxyvitamin D in vascular calcification and mortality in fibroblastic growth factor 23 null mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.111

Ablation of vitamin D signaling rescues bone, mineral, and glucose homeostasis in Fgf-23 deficient mice.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.111

Premature aging-like phenotype in fibroblast growth factor 23 null mice is a vitamin D-mediated process

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.111

Reversal of mineral ion homeostasis and soft-tissue calcification of klotho knockout mice by deletion of vitamin D 1alpha-hydroxylase

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.111

Dietary and genetic evidence for phosphate toxicity accelerating mammalian aging

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.111

Targeted inactivation of Npt2 in mice leads to severe renal phosphate wasting, hypercalciuria, and skeletal abnormalities

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.111

In vivo genetic evidence for suppressing vascular and soft-tissue calcification through the reduction of serum phosphate levels, even in the presence of high serum calcium and 1,25-dihydroxyvitamin d levels

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.111

Hyperphosphatemia of chronic kidney disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.111

Chronic kidney disease: a clinical model of premature aging

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.111

Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.111

Severely reduced production of klotho in human chronic renal failure kidney.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.111

Parathyroid cell resistance to fibroblast growth factor 23 in secondary hyperparathyroidism of chronic kidney disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.111

Depressed expression of Klotho and FGF receptor 1 in hyperplastic parathyroid glands from uremic patients.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.111

Parathyroid Klotho and FGF-receptor 1 expression decline with renal function in hyperparathyroid patients with chronic kidney disease and kidney transplant recipients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.111

Involvement of alpha-klotho and fibroblast growth factor receptor in the development of secondary hyperparathyroidism.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.111

Serum phosphate levels and mortality risk among people with chronic kidney disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.111

Prevention and control of phosphate retention/hyperphosphatemia in CKD-MBD: what is normal, when to start, and how to treat?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.111

DNA repair, genome stability, and aging

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.111

Longevity, Stress Response, and Cancer in Aging Telomerase-Deficient Mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.111

Telomere shortening triggers senescence of human cells through a pathway involving ATM, p53, and p21(CIP1), but not p16(INK4a)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.111

p53 deficiency rescues the adverse effects of telomere loss and cooperates with telomere dysfunction to accelerate carcinogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.111

Cdkn1a deletion improves stem cell function and lifespan of mice with dysfunctional telomeres without accelerating cancer formation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.111

p53 mutant mice that display early ageing-associated phenotypes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.111

A new progeroid syndrome reveals that genotoxic stress suppresses the somatotroph axis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.111

Lifespan extension and delayed immune and collagen aging in mutant mice with defects in growth hormone production

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.111

Stress-induced premature senescence in mononuclear cells from patients on long-term hemodialysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.111

31 March 2020

Liver metabolism in CRF.

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.111

Inhibition of growth hormone signaling by the fasting-induced hormone FGF21.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.111

Circulating FGF21 levels are progressively increased from the early to end stages of chronic kidney diseases and are associated with renal function in Chinese

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.111

Serum fibroblast growth factor-21 concentration is associated with residual renal function and insulin resistance in end-stage renal disease patients receiving long-term peritoneal dialysis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.111

The starvation hormone, fibroblast growth factor-21, extends lifespan in mice.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.111

Increased inorganic phosphate induces human endothelial cell apoptosis in vitro

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.111

Dietary phosphorus acutely impairs endothelial function

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.111

Smooth muscle cell phenotypic transition associated with calcification: upregulation of Cbfa1 and downregulation of smooth muscle lineage markers.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.111

Phosphate regulation of vascular smooth muscle cell calcification

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.111

Human vascular smooth muscle cells undergo vesicle-mediated calcification in response to changes in extracellular calcium and phosphate concentrations: a potential mechanism for accelerated vascular calcification in ESRD.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.111

Hyperphosphatemia-induced nanocrystals upregulate the expression of bone morphogenetic protein-2 and osteopontin genes in mouse smooth muscle cells in vitro

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.111

Phosphonoformic acid prevents vascular smooth muscle cell calcification by inhibiting calcium-phosphate deposition.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.111

Calcium phosphate crystals induce cell death in human vascular smooth muscle cells: a potential mechanism in atherosclerotic plaque destabilization

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.111

Role of the sodium-dependent phosphate cotransporter, Pit-1, in vascular smooth muscle cell calcification

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.111

Mineral phases of calcium phosphate

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.111

Spontaneous precipitation of brushite in urine: evidence that brushite is the nidus of renal stones originating as calcium phosphate

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.111

Fetuin-A is a mineral carrier protein: small angle neutron scattering provides new insight on Fetuin-A controlled calcification inhibition

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.111

A shielding topology stabilizes the early stage protein-mineral complexes of fetuin-A and calcium phosphate: a time-resolved small-angle X-ray study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.111

Structural dynamics of a colloidal protein-mineral complex bestowing on calcium phosphate a high solubility in biological fluids

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.111

Structural basis of calcification inhibition by alpha 2-HS glycoprotein/fetuin-A. Formation of colloidal calciprotein particles

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.111

The serum protein alpha 2-Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.111

Phosphate-dependent stimulation of MGP and OPN expression in osteoblasts via the ERK1/2 pathway is modulated by calcium

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.111

Clearance of fetuin-A--containing calciprotein particles is mediated by scavenger receptor-A.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.111

Fetuin-mineral complex reflects extraosseous calcification stress in CKD

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.111

Fully phosphorylated fetuin-A forms a mineral complex in the serum of rats with adenine-induced renal failure

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.111

Phosphorylated fetuin-A-containing calciprotein particles are associated with aortic stiffness and a procalcific milieu in patients with pre-dialysis CKD

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.111

Effects of phosphate binders in moderate CKD

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.111

Calcium deficiency reduces circulating levels of FGF23.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.111

RENAL DAMAGE FOLLOWING THE INGESTION OF A DIET CONTAINING AN EXCESS OF INORGANIC PHOSPHATE

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.111

Acute phosphate nephropathy-an emerging threat

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.111

Renal toxicity of phosphate in rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.111

A micropuncture study of renal phosphate transport in rats with chronic renal failure and secondary hyperparathyroidism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.111

Phosphate excess and progressive renal failure: the precipitation-calcification hypothesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.111

Calcium phosphate-induced renal epithelial injury and stone formation: involvement of reactive oxygen species

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.111

The kidney and bisphosphonates

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.111

Diphosphonates inhibit formation of calcium phosphate crystals in vitro and pathological calcification in vivo.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.111

Human nephron number: implications for health and disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.111

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.111

Long-term consequences of kidney donation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.111

Effects of aging on glomerular function and number in living kidney donors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.111

Bone and mineral metabolism and fibroblast growth factor 23 levels after kidney donation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.111

The distribution of urinary calcium excretions in normal persons and stone-formers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.111

Intestinal calcium absorption and serum vitamin D metabolites in normal subjects and osteoporotic patients: effect of age and dietary calcium

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.111

High citrate diet delays progression of renal insufficiency in the ClC-5 knockout mouse model of Dent's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.111

Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.111

Direct evidence for a causative role of FGF23 in the abnormal renal phosphate handling and vitamin D metabolism in rats with early-stage chronic kidney disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.111

Effects of dietary phosphate and calcium intake on fibroblast growth factor-23

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.111

Dietary phosphorus regulates serum fibroblast growth factor-23 concentrations in healthy men.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.111

Effect of acute changes of serum phosphate on fibroblast growth factor (FGF)23 levels in humans

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.111

Fibroblast growth factor 23, cardiovascular disease risk factors, and phosphorus intake in the health professionals follow-up study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.111

Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.111

Prevalence of chronic kidney disease in the United States

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.111

Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.111

The new KDOQI clinical practice guidelines and clinical practice recommendations for diabetes and CKD

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.111

Assessment of renal fibrosis with diffusion-weighted MR imaging: study with murine model of unilateral ureteral obstruction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.111

Klotho inhibits transforming growth factor-beta1 (TGF-beta1) signaling and suppresses renal fibrosis and cancer metastasis in mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.111

Dietary phosphorus restriction in advanced chronic kidney disease: merits, challenges, and emerging strategies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.111

Vegetarian compared with meat dietary protein source and phosphorus homeostasis in chronic kidney disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.111

Physiological Responses of Human Adults to Foods Containing Phosphate Additives

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.111

Nanoparticle-based test measures overall propensity for calcification in serum

31 March 2020

1 reference

12 December 2020

The parathyroid is a target organ for FGF23 in rats

1 reference

12 December 2020

Association of elevated serum PO(4), Ca x PO(4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients

1 reference

12 December 2020

Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism

1 reference

12 December 2020

Genetic syndromes in man with potential relevance to the pathobiology of aging

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRNEPH.2013.111

1 reference

PubMed ID

23774819

Dimensions Publication ID

29 August 2017

0 references

1 reference

PubMed ID

23774819